Man­u­fac­tur­ing roundup: Cana­da to in­vest $58M+ in­to 'crit­i­cal' med­i­cines man­u­fac­tur­ing; FDA to ac­cept apps for CMC pi­lot

Cana­da’s gov­ern­ment will in­vest $58.6 mil­lion over five years to sup­port the Cana­di­an Crit­i­cal Drug ini­tia­tive and 350 jobs.

The ini­tia­tive plans to boost the R&D and man­u­fac­tur­ing sec­tor in the province of Al­ber­ta and is spear­head­ed by the not-for-prof­it Ap­plied Phar­ma­ceu­ti­cal In­no­va­tion (API), which helps life sci­ence com­pa­nies in the com­mer­cial­iza­tion phase.

The fund­ing will help push for­ward a new 40,000 square foot man­u­fac­tur­ing site in Ed­mon­ton to pro­duce “crit­i­cal” med­i­cines, but the spe­cif­ic prod­ucts were not im­me­di­ate­ly an­nounced. The fa­cil­i­ty, once com­plet­ed, will be able to pro­duce 70 mil­lion dos­es an­nu­al­ly. The funds will al­so go to­ward up­grad­ing API’s ex­ist­ing R&D fa­cil­i­ty in Ed­mon­ton as well as oth­er R&D pro­grams and clin­i­cal tri­al sup­port.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.